NICE draft RA recommendations leave "little hope for patients"
This article was originally published in Scrip
NICE, the health technology appraisal body for England and Wales, today published draft recommendations saying that rheumatoid arthritis (RA) patients should only be prescribed a second TNF-inhibitor as part of clinical research.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.